Law360, New York (October 08, 2010, 1:17 PM ET) -- A New Jersey jury has found in favor of Novartis Pharmaceuticals Corp. in a suit brought by a woman who claimed she developed osteonecrosis of the jaw as a result of Aredia and Zometa, marking the second jury verdict to come down in hundreds of cases over the bone-strengthening drugs.
Following two hours of deliberation and a 10-day trial, the jury on Wednesday rejected Jane and Allen Bessemer's claim that Novartis failed to furnish Jane Bessemer's doctor with adequate warning about the risk of jaw problems...
Novartis Prevails In 2nd Trial Over Bone Drug Liability
To view the full article, take a free trial now.
